Year: 2020

news_6

FDA Accepts Shionogi’s Supplemental New Drug Application with Priority Review for FETROJA® (cefiderocol) for the Treatment of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

news_6

Benchmark International Successfully Facilitated the Transaction Between Oasis Water Holdings (PTY) LTD and Both Fledge Capital (PTY) LTD & SLA Capital (PTY) LTD

Capetown, South Africa, May 31, 2020 --(PR.com)-- Benchmark International is pleased to have successfully facilitated the transaction between Oasis Water...